APA

López De Padilla C. M., Crowson C. S., Hein M. S., Strausbauch M. A., Aggarwal R., Levesque M. C., Ascherman D. P., Oddis C. V. & Reed A. M. (20151216). Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab. : Clinical and experimental rheumatology.

Chicago

López De Padilla Consuelo M, Crowson Cynthia S, Hein Molly S, Strausbauch Michael A, Aggarwal Rohit, Levesque Marc C, Ascherman Dana P, Oddis Chester V and Reed Ann M. 20151216. Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab. : Clinical and experimental rheumatology.

Harvard

López De Padilla C. M., Crowson C. S., Hein M. S., Strausbauch M. A., Aggarwal R., Levesque M. C., Ascherman D. P., Oddis C. V. and Reed A. M. (20151216). Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab. : Clinical and experimental rheumatology.

MLA

López De Padilla Consuelo M, Crowson Cynthia S, Hein Molly S, Strausbauch Michael A, Aggarwal Rohit, Levesque Marc C, Ascherman Dana P, Oddis Chester V and Reed Ann M. Interferon-regulated chemokine score associated with improvement in disease activity in refractory myositis patients treated with rituximab. : Clinical and experimental rheumatology. 20151216.